A Lack of Faith?

Regarding the "disregard syndrome,"1 and various opinions expressed thereafter, there is a deliberate disregard for the scientific papers published from India (probably from other developing countries as well). I can quote numerous examples where a paper on a precise topic ignores mentioning related work already done in certain countries, although those papers have appeared in journals that are included in Medline, Current Contents, and other sources. This may partly be due to lack of faith/rega

Written byKalluri Subba Rao
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Regarding the "disregard syndrome,"1 and various opinions expressed thereafter, there is a deliberate disregard for the scientific papers published from India (probably from other developing countries as well). I can quote numerous examples where a paper on a precise topic ignores mentioning related work already done in certain countries, although those papers have appeared in journals that are included in Medline, Current Contents, and other sources. This may partly be due to lack of faith/regard for what has been done since the information is ignored even if it was complementary and supporting. Science by its very nature demands, in an unqualified way, honesty and respect for other scientists' findings and opinion. This must be sustained in spite of the growing competition in the race for glory and perhaps money. If not, we may have to separate science from science business.
Kalluri Subba Rao
Professor, Biochemistry
University of Hyderabad
Hyderabad- 500 046. India.
ksrsl@uohyd.ernet.in

1. I. Ginsburg, "The disregard syndrome: A menace to honest science?" The Scientist, 15[24]:51, Dec. 10, 2001.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies